| Headlines |
"Emperor of All Maladies" Author to Speak at Annual Meeting
| Dr. Siddhartha Mukherjee, Pulitzer Prize-winning author of “The Emperor of All Maladies: A Biography of Cancer”, will speak on Tuesday, October 18, at the AACI/CCAF Annual Meeting in Washington, D.C. In keeping with the association’s recognition of the 40th anniversary of the National Cancer Act of 1971, Dr. Mukherjee will share with AACI members his historical perspective on the past four decades of cancer research. He will also receive the AACI Excellence in Cancer Communications Award. (Photo by Deborah Feingold)
more... |
|
|
Cancer Genetics Expert to Lead Abramson
| Chi Van Dang, MD, PhD, a renowned cancer biologist and hematologist-oncologist, has been appointed director of the Abramson Cancer Center of the University of Pennsylvania. Dr. Dang is currently a professor at The Johns Hopkins University School of Medicine in the departments of Medicine, Cell Biology, Oncology, Pathology, and Molecular Biology & Genetics.
more... |
|
|
Gilbertson New Director at St. Jude
| St. Jude Children’s Research Hospital officials have named Richard Gilbertson, MD, PhD, director of its Comprehensive Cancer Center and an executive vice president in the organization. St. Jude is home to the first and only National Cancer Institute (NCI)-designated Comprehensive Cancer Center devoted solely to children. It has been an NCI-designated Cancer Center since 1977 and was named a comprehensive center in 2008.
more... |
|
|
Cleveland Clinic Appoints Cancer Institute Chairman
Cleveland Clinic has appointed Brian J. Bolwell, MD, as chairman of the Taussig Cancer Institute. Dr. Bolwell, a 24-year Cleveland Clinic veteran, will lead one of the country’s largest and most respected cancer programs.
Dr. Bolwell became the Interim Chair of the Taussig Cancer Institute in 2010. He has served as Director of the Bone Marrow Transplant Program since 1988 and as Chairman of the Department of Hematologic Oncology and Blood Disorders since 2006. He also served as President of the Professional Staff of the Cleveland Clinic Foundation from 2004-2005. Dr. Bolwell is Professor of Medicine at the Cleveland Clinic Lerner School of Medicine, and he joined Cleveland Clinic in 1987.
more... |
|
|
AACI Members Select Le Beau President-Elect, Torti for Board of Directors
Michelle M. Le Beau, PhD, director of The University of Chicago Comprehensive Cancer Center (UCCCC,) has been elected Vice President/President-elect of the Association of American Cancer Institutes.
Dr. Le Beau became the Cancer Center director in 2004 and the center received its National Cancer Institute designation in 2008. She is also director of The University of Chicago’s Cancer Cytogenetics Laboratory and is the inaugural Arthur and Marian Edelstein Professor of Medicine, an award recognizing distinction as a teacher and as a scholar in cancer research.
AACI members have also chosen Frank M. Torti, MD, MPH, for the association’s board of directors. Dr. Torti is director of the Comprehensive Cancer Center of Wake Forest University, in Winston-Salem, NC, and the Charles L. Spurr Professor of Medicine and chair of the department of cancer biology at Wake Forest. Dr. Torti was principal deputy commissioner and first chief scientist to the U.S Food and Drug Administration from 2008 to 2009.
more... |
|
|
Clinical Research Initiative Convenes in Chicago
| AACI’s Clinical Research Initiative (CRI) held its third annual membership meeting in July in Chicago. Attendance was 52 percent higher compared to the inaugural general meeting in 2009. The meeting included an update from NCI leadership on plans for transforming the clinical trials enterprise. More meeting news and the latest AACI CRI Quarterly Newsletter are available here http://aaci-cancer.org/cri/pdf/CRIAugust2011Newsletter.pdf
more... |
|
|
Call for Submissions to AACI Update
|
This issue of AACI Update launches a fresh new look for one of the association’s chief communications tools. Notably, introductory text for “News From the Centers” items has been trimmed to make room for more stories. Currently, about one-third of AACI’s members submit news each month; we invite all 94 of our members to spread the word about the good work at their centers by sending press releases to aaciupdate@aaci-cancer.org. Submission guidelines are available at http://www.aaci-cancer.org/submissionguidelines.asp.
more... |
|
National Cancer Act 40th Anniversary: Schmidt Carries Fight Forward
To mark the 40th anniversary of the National Cancer Act of 1971, each 2011 issue of AACI Update will include a story about the history of the legislation’s passage.
With no end in sight for the Vietnam War and a presidential election approaching, Benno C. Schmidt, Sr. met with President Richard Nixon in the fall of 1971 to propose a compromise between competing U.S. House and Senate cancer bills. Nixon assured Schmidt that he would find a solution to the stalemate.
more... |
L to R: Benno Schmidt, Sr. (Sloan-Kettering), President Richard Nixon, R. Lee Clark (President, MD Anderson Cancer Center), and Robert A. Good at the Conquest of Cancer Program, The White House, 1973. |
|
| News from the Centers |
|
|
|
Awards & Honors
|
Lauer to Serve on ASCO Committee Examining Cancer Quality, Cost
University of New Mexico Cancer Center
Richard Lauer, MD, Executive Medical Director of the University of New Mexico Cancer Center and a specialist in blood and urologic cancers, has accepted an invitation to serve on the American Society of Clinical Oncology’s new Provider-Payer Initiative Workgroup.
more... |
|
 |
Demark-Wahnefried Is President-Elect of American Society of Preventive Oncology
UAB Comprehensive Cancer Center
Wendy Demark-Wahnefried, PhD, professor in the Department of Nutrition Sciences and associate director for cancer prevention and control at the UAB Comprehensive Cancer Center, has been named president-elect of the American Society of Preventive Oncology.
more... |
|
 |
American Society of Hematology Honors Druker
Knight Cancer Institute
The American Society of Hematology (ASH) recognized Brian Druker, MD, director of the Oregon Health & Science University Knight Cancer Institute, along with Janet Rowley, MD, of the University of Chicago Medical Center, with the 2011 Ernest Beutler Lecture and Prize for their significant advances in the diagnosis and treatment of chronic myeloid leukemia.
more... |
|
 |
Cohn Honored by Alex’s Lemonade Stand Foundation
University of Chicago Comprehensive Cancer Center
Susan Cohn, MD, professor of pediatrics, has been awarded a 2011 Innovation Award from the Alex’s Lemonade Stand Foundation.
more... |
|
|
Grants & Gifts
|
Hawaii Receives Liver Cancer Research Grant
Cancer Research Center of Hawaii
Two scientists from the University of Hawaii Cancer Center and The Queen’s Medical Center have received a five-year $2.3 million grant from the National Cancer Institute to develop novel methods that can better detect liver cancer through the joint analysis of gene expression and imaging data of the liver.
more... |
|
Greenbaum Receives Renewal of NCI Designation
University of Maryland Greenebaum Cancer Center
The University of Maryland Marlene and Stewart Greenebaum Cancer Center has won renewal of its National Cancer Institute (NCI) designation for five years, along with $7.6 million in new federal funding for cancer research.
more... |
|
$30 Million Gift Creates New Center for Personalized Cancer Care
Sidney Kimmel Comprehensive Cancer Center
A $30 million gift from the Commonwealth Foundation for Cancer Research has enabled the Johns Hopkins Kimmel Cancer Center to establish a Center for Personalized Cancer Medicine.
more... |
|
 |
AT&T gives to UAMS Nanomedicine to Honor Patti Upton
Winthrop P. Rockefeller Cancer Institute
AT&T Arkansas has made a $250,000 contribution in honor of outgoing board member Patti Upton to support the nanomedicine research program in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS).
more... |
|
|
Leadership Transitions
|
Vanderbilt-Ingram Cancer Center Announces Leadership Changes
Vanderbilt-Ingram Cancer Center
Two senior faculty members at Vanderbilt-Ingram Cancer Center have been promoted to new leadership roles. Carlos L. Arteaga, MD, professor of Medicine and Cancer Biology and director of the Breast Cancer Program, has accepted a new role as associate director for Clinical Research. R. Daniel Beauchamp, MD, who previously held the position, will become deputy director of the cancer center.
more... |
|
Nanobiotechnology Expert to Join Faculty
Lucille P. Markey Cancer Center
Peixuan Guo, MS, PhD, director of the National Cancer Institute Cancer Nanotechnology Platform Partnerships Program at the University of Cincinnati and one of the world’s top nanobiotechnology experts, will join the Markey Cancer Center.
more... |
|
 |
Ohio State Names Cohn Director Of Gynecologic Oncology
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
David E. Cohn, MD, has been appointed director of the division of gynecologic oncology in the department of obstetrics and gynecology at The Ohio State University College of Medicine.
more... |
|
 |
City of Hope Names New Vice President and Chief Pharmacy Officer
City of Hope National Medical Center and Beckman Research Institute
City of Hope has appointed Dan Ross, PharmD, as vice president and chief pharmacy officer. Ross will oversee all pharmacy services as well as City of Hope’s pathology, diagnostic radiology and radiation oncology departments.
more... |
|
 |
Drake Joins Hollings to Lead Proteomics Center
Hollings Cancer Center
Richard R. Drake, PhD, has joined the Hollings Cancer Center at the Medical University of South Carolina as director of the Proteomics Center. He and his colleagues work to develop new diagnostic tests to define how well cancer treatments are working.
more... |
|
 |
Champion Named Associate Director of Population Science
Indiana University Melvin and Bren Simon Cancer Center
Victoria Champion, PhD, RN, FAAN, Distinguished Professor at the Indiana University School of Nursing, has been named associate director of population science at the Indiana University Melvin and Bren Simon Cancer Center.
more... |
|
Muller Tapped for NIH Clinical Oncology Study Section
University of New Mexico Cancer Center
Carolyn Muller, MD, University of New Mexico Professor of Obstetrics and Gynecology and Director of Gynecologic Oncology at the UNM Cancer Center, has been tapped for the NIH’s Clinical Oncology Study Section, which reviews grant applications in patient-oriented research and clinical therapeutic trials, areas that ensure the safe and timely delivery of cutting-edge treatments to patients.
more... |
|
 |
Leading Cancer Researcher Joins Emory University
Winship Cancer Institute
Deborah Watkins Bruner, PhD, RN, FAAN, an internationally recognized authority on cancer care and quality of life, has been appointed to the faculty at Emory University. Bruner will hold a dual appointment as a professor of nursing at Emory’s Nell Hodgson Woodruff School of Nursing and as associate director of cancer outcomes at Winship Cancer Institute of Emory University.
more... |
|
 |
Lollo Named to New Siteman Post
The Alvin J. Siteman Cancer Center
Trisha Lollo has been named vice president of cancer services for the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. Lollo currently serves as associate administrator of oncology services for the University of California, San Diego Health System.
more... |
|
Massey Gets New Division Chair of Hematology, Oncology and Palliative Care
Massey Cancer Center
Steven R. Grossman, MD, PhD, has been named division chair in the Division of Hematology, Oncology and Palliative Care in the Virginia Commonwealth University School of Medicine and at VCU Massey Cancer Center. Grossman, an expert in gastrointestinal cancers, comes to VCU from the University of Massachusetts Medical School.
more... |
|
|
Research Highlights
|
 |
Better Method Developed to Manage Chemotherapy in Geriatric Patients
City of Hope National Medical Center and Beckman Research Institute
Arti Hurria, MD, associate professor in City of Hope’s Department of Medical Oncology & Therapeutics Research, is the lead author of a prospective multicenter study investigating a new system to predict chemotherapy toxicity specifically in older patients.
more... |
|
 |
Study: Expectations about Prostate Cancer Surgery Recovery Overly Optimistic
University of Michigan Comprehensive Cancer Center
Nearly half of men undergoing surgery for prostate cancer expect better recovery from the side effects of the surgery than they actually attain one year after the operation, a University of Michigan Comprehensive Cancer Center study finds. Study author Daniela Wittmann, MSW, is sexual health coordinator at the U-M prostate cancer survivorship program.
more... |
|
 |
Researchers Uncover Reason Why the Human Heart Cannot Regenerate
Jonsson Comprehensive Cancer Center, UCLA
Stem cell researchers at UCLA have uncovered for the first time why adult human cardiac myocytes have lost their ability to proliferate, perhaps explaining why the human heart has little regenerative capacity. Robb MacLellan, MD, a researcher with the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, was senior author of the study.
more... |
|
 |
Sentinel Node Biopsy Safe, Effective in Head and Neck Melanomas
University of Michigan Comprehensive Cancer Center
University of Michigan researchers have found that use of sentinel lymph node biopsy is safe and effective when melanoma occurs in the head and neck. Carol Bradford, MD, professor and chair of otolaryngology at the U-M Medical School, was the study’s lead author.
more... |
|
 |
Common Pain Drugs Reduces Severity of Postpartum Breast Cancers
University of Colorado Cancer Center
University of Colorado Cancer Center researchers Pepper Schedin, PhD, and Virginia Borges, MD, have found that non-steroidal anti-inflammatory drugs including ibuprofen reduce the severity of postpartum breast cancers in animal models.
more... |
|
 |
New Non-Invasive Technology Shows Promise in Shrinking Liver Tumors
UAB Comprehensive Cancer Center
In a phase II study, 41 patients with hepatocellular carcinoma (HCC), a liver cancer that often does not respond well to chemotherapy, were treated with very low levels of an electromagnetic field emitting from a spoon-like device placed in the patients’ mouths. After six months, the tumors in 14 patients had stabilized after each received three one-hour treatments per day each day; the therapy created no significant side effects.
more... |
|
 |
Researchers Identify Seventh and Eighth Bases of DNA
UNC Lineberger Comprehensive Cancer Center
Researchers from the UNC School of Medicine have discovered the seventh and eighth bases of DNA. Called 5-formylcytosine and 5 carboxylcytosine, they are versions of cytosine that have been modified by Tet proteins, molecular entities thought to play a role in DNA demethylation and stem cell reprogramming. Yi Zhang, PhD, is senior author of the study, published in the journal Science.
more... |
|
 |
Scientists Develop Method to Determine Order of Mutations that Lead to Cancer
Knight Cancer Institute
In a study published in the journal Cancer Discovery, researchers focused on assessing mutations involving TP53, a gene that normally prevents cells from becoming cancerous. By examining how additional copies of the mutant gene accumulated, they found that changes in TP53 occurred earlier in the progression of skin and ovarian tumors than previously believed. Joe Gray, Ph.D., associate director for translational research for the OHSU Knight Cancer Institute, was part of the research team.
more... |
|
 |
Center to Focus on Genetics of Childhood Cancer
The Dan L. Duncan Cancer Center
The new Pediatric Center for Personal Cancer Genomics and Therapeutics has been launched at Baylor College of Medicine through a partnership between the Texas Children’s Cancer Center and the Human Genome Sequencing Center at BCM. Will Parsons, MD, PhD, is center director, assistant professor of pediatrics – hematology/oncology at BCM and a pediatric oncologist at Texas Children’s Cancer Center.
more... |
|
Enzyme May Drive Breast Cancer Growth
University of Illinois at Chicago Cancer Center
A recently discovered enzyme drives the production of a potent form of estrogen in human breast cancer tissue, researchers from the University of Illinois at Chicago College of Medicine have found.
more... |
|
Centers Collaborate to Reveal Unexpected Genetic Mutations
University of Pittsburgh Cancer Institute
Powerful new technologies that zoom in on the connections between human genes and diseases have illuminated the landscape of cancer, singling out changes in tumor DNA that drive the development of certain types of malignancies. Now several major biomedical centers have collaborated to shine a light on head and neck squamous cell cancer.
more... |
|
 |
First Large-Scale Map of a Plant’s Protein Network Addresses Evolution, Disease Process
Dana-Farber Cancer Institute
In a study in the journal Science, scientists at Dana-Farber Cancer Institute’s Center for Cancer Systems Biology and an international team of colleagues capture the first evidence of the evolutionary process within networks of plant proteins. In a companion article explores how microbes like bacteria and fungi undermine plants’ defenses against disease. Dana-Farber’s Pascal Braun, PhD, had a leading role in both studies.
more... |
|
PET Scans Confirm Effectiveness of Estrogen-Blocking Drugs
Fred Hutchinson Cancer Research Center
For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer. The results of the research are published online in Clinical Cancer Research.
more... |
|
Novel Combined Therapy for Brain Cancer Patients
Rebecca and John Moores UCSD Cancer Center
Santosh Kesari, MD, PhD, at the University of California, San Diego School of Medicine and colleagues have utilized a novel combined technique to treat cancer patients by bathing the brain in chemotherapy and relieving pressure from spinal fluid build-up.
more... |
|
Menthol Cigarettes May Make it Tougher to Quit Smoking for Certain Populations
The Cancer Institute of New Jersey
Investigators at The Cancer Institute of New Jersey (CINJ) and UMDNJ-School of Public Health have found that menthol cigarettes are associated with decreased quitting in the United States, and that this effect is more pronounced for blacks and Puerto Ricans.
more... |
|
 |
Small Molecules Play Complex Roles in Cancer Metastasis
The Cancer Institute of New Jersey
While they may be small in size, a family of tiny molecules called microRNAs could potentially play a large role in the process of cancer metastasis, or the spread of cancer from one area of the body to another.
more... |
|
Study Urges Caution With Lenalidomide Dosage
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
An early phase multiple myeloma trial has unexpectedly revealed that the drug lenalidomide interacts with another protein in cells that affect its dose level in the body.
more... |
|
Link Between Immune System Suppression and Blood Vessel Formation in Tumors
Abramson Cancer Center of the University of Pennsylvania
Targeted therapies that are designed to suppress the formation of new blood vessels in tumors, such as Avastin (bevacizumab), have slowed cancer growth in some patients. However, they have not produced the dramatic responses initially expected. Now, research from the Perelman School of Medicine at the University of Pennsylvania might help to explain the modest responses.
more... |
|
 |
Dietary-Intervention Study for Prostate Cancer Accruing Patients
Roswell Park Cancer Institute
Roswell Park Cancer Institute has opened a clinical trial that will assess the impact of dietary change to control prostate cancer. The Men’s Eating and Living (MEAL) study is led by co-investigators James Mohler, MD, and James Marshall, PhD.
more... |
|
Esophageal Cancer Risk Higher in Medically Treated GERD Patients with Fewest Symptoms
University of Pittsburgh Cancer Institute
Medically treated patients with mild or no symptoms of gastroesophageal reflux disease (GERD) are at higher risk for developing esophageal cancer than those with severe GERD symptoms, according to a University of Pittsburgh study published in Archives of Surgery.
more... |
|
 |
New Points of Attack on Breast Cancers not Fueled by Estrogen
Dana-Farber Cancer Institute
Scientists at Dana-Farber Cancer Institute have provided details on the cancer cell machinery that causes the male hormone androgen to spur the growth of some breast tumors in women. Myles Brown, MD, is senior author of the study, published in the journal Cancer Cell.
more... |
|
 |
Clinically Relevant Changes in Familial Cancer History Most Significant in Early Adulthood
The Dan L. Duncan Cancer Center
A multi-institutional report published in the Journal of the American Medical Association sheds new light on how often, and at what age, a patient’s family history of cancer should be updated. Sharon Plon, MD, PhD, director of the Baylor College of Medicine Cancer Genetics Clinic and a professor of pediatrics and of molecular and human genetics at BCM, is a senior author of the report.
more... |
|
 |
First Genetic Sequencing of Bladder Cancer
University of Colorado Cancer Center
Recognizing the genetic mutations that make bladder cancer cells different than their healthy neighbors may allow early genetic screenings for cancer and new therapies targeting cells with these mutations.
more... |
|
 |
Lung Cancer Study Suggests New Therapy Schedule for Tumors
Vanderbilt-Ingram Cancer Center
A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that some non-small cell lung cancer cells grow at different rates, which may explain why some tumors become resistant to anticancer drugs faster than others. Based on the differential growth rates, the study suggests that a change in the timing and dosages of certain therapies may be effective in delaying the onset of resistance to therapy.
more... |
|
 |
Roswell Park, Cleveland Biolabs Publish Curaxin Findings
Roswell Park Cancer Institute
A paper published by Science Translational Medicine outlines the process by which a category of anticancer drugs called curaxins inhibit tumor cell growth and division. Roswell Park Cancer Institute researcher Katerina Gurova, MD, PhD, was the study’s principal investigator.
more... |
|
 |
Vitamin D Relieves Joint, Muscle Pain for Breast Cancer Patients
The Alvin J. Siteman Cancer Center
High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.
more... |
|
 |
New Recommendations for Surgical Treatment of Women with Breast Cancer
Memorial Sloan-Kettering Cancer Center
A multicenter study led by Monica Morrow, MD, Chief of Memorial Sloan-Kettering’s Breast Service in the Department of Surgery, has found that for women who meet certain criteria--about 20 percent of all breast cancer patients--axillary node dissection, is unnecessary and does not improve survival or reduce rates of recurrence.
more... |
|
Five Inherited Genetic Variants Could Help Identify Lethal Prostate Cancers
Fred Hutchinson Cancer Research Center
An international team of researchers led by Fred Hutchinson Cancer Research Center has identified five inherited genetic variants that are strongly associated with aggressive, lethal prostate cancer.
more... |
|
 |
Combo Therapies Tested to Overcome Drug Resistance in Melanoma
Jonsson Comprehensive Cancer Center, UCLA
In a study published as a Priority Report in the peer-reviewed journal Cancer Research, scientists at UCLA’s Jonsson Comprehensive Cancer Center tested a combination of small molecules that may, when used with the BRAF inhibitors, help overcome drug resistance and extend the lives of those with advanced melanoma.
more... |
|
Bone Marrow Transplantation May Increase Cancer Resistance in Patients
Lucille P. Markey Cancer Center
Bone marrow transplantation with genetically modified cells may prolong the period of cancer-free survival, suggests a study led by Vivek Rangnekar, PhD, associate director of translational research for the Markey Cancer Center at the University of Kentucky.
more... |
|
Lycopene May Help Prevent Prostate Cancer in African Americans
University of Illinois at Chicago Cancer Center
Lycopene, a red pigment that gives tomatoes and certain other fruits and vegetables their color, could help prevent prostate cancer, especially in African American men, according to new research at the University of Illinois at Chicago.
more... |
|
 |
Genetic Variations Predict Second Cancers for Pediatric Hodgkin Lymphoma Patients
University of Chicago Comprehensive Cancer Center
Kenan Onel, MD, PhD, and colleagues can now predict which patients with Hodgkin lymphoma are most likely to develop radiation therapy-induced second cancers years after treatment.
more... |
|
NIH-funded Researchers Discover Genetic Link to Mesothelioma
Fox Chase Cancer Center
Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer — mesothelioma, and melanoma of the eye. The study describes two U.S. families with a high incidence of mesothelioma, as well as other cancers, associated with mutations of the BAP1 gene. The research was funded by the National Cancer Institute and led by scientists at the University of Hawaii Cancer Center, Honolulu, and Fox Chase Cancer Center, Philadelphia.
more... |
|
 |
Researcher Focuses on Lipid Signalling
Hollings Cancer Center
Lena Obeid, MD, head of the of the Lipid Signaling in Cancer program at Hollings Cancer Center at the Medical University of South Carolina (MUSC), has published the manuscript, "Defining a role for sphingosine kinase 1 in p53-dependent tumors", in the journal Oncogene.
more... |
|
Researcher Discovers Mechanism Responsible for Advancement of Myeloma, Resistance to Treatment
USC/Norris Comprehensive Cancer Center
Research at the Keck School of Medicine, conducted with other scientists, has shown that a cellular-signaling mechanism spurs the advancement of multiple myeloma, a bone-marrow cancer accounting for 10 percent of all blood-borne malignancies, and also makes the disease resistant to drugs.
more... |
|
|
Other News
|
 |
North Carolina Community Colleges Partner to Prevent Cancer
UNC Lineberger Comprehensive Cancer Center
UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center are partnering with North Carolina’s 58 community colleges to assess needs and preferences for adopting and implementing evidence based interventions for cancer prevention that are suitable for students, employees and community residents. Laura Linnan, ScD, CHES, is the project’s principal investigator.
more... |
|
Moffitt Appoints New Members To National Board Of Advisors
Moffitt Cancer Center
Moffitt Cancer Center has appointed three new members to its national Board of Advisors: Elizabeth (Liz) A. Smith, chief executive officer of OSI Restaurant Partners, LLC; John Tomlin, president and CEO of AAA Auto Club South and CEO of Auto Club South Insurance Company; and, Nick Valvano, CEO of The V Foundation for Cancer Research.
more... |
|
KCI Gains Two Nobel Laureates on its External Advisory Board
Barbara Ann Karmanos Cancer Institute
Nobel laureates Phillip A. Sharp, PhD, institute professor at the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology; and Harald zur Hausen, MD, DSc, professor emeritus at the German Cancer Research Center in Heidelberg, Germany, are new members of the Barbara Ann Karmanos Cancer Insitute’s External Advisory Board.
more... |
|
Merger Complete for The University of Kansas Cancer Center and Kansas City Cancer Center
University of Kansas Cancer Center
Kansas City’s two preeminent cancer care programs, The University of Kansas Cancer Center and Kansas City Cancer Center (KCCC), have completed their merger. The newly merged organization will have 52 medical and radiation oncologists working in 12 locations throughout the Greater Kansas City metropolitan area.
more... |
|
| Job Opportunities
|
Phase II Network Administrator
University of Chicago Comprehensive Cancer Center
more...
Research Administration: Associate Director for Research Institute
The University of Hawaii Cancer Center
University of Hawaii at Manoa
more...
Sr. Executive Director, Clinical Trial Operations
The University of Kansas Cancer Center
more...
Clinical Research Nurse Administrator
Massey Cancer Center
Virginia Commonwealth University
more...
Director of Nursing Quality
The Ohio State University Comprehensive Cancer Center–
Arthur G. James Cancer Hospital
more...
Senior Director of Development
University of New Mexico Cancer Center
more...
Administrative Director
St. Jude Children’s Research Hospital
more...
Director, Business Development for the Greenebaum Cancer Center
The University of Maryland
Greenebaum Cancer Center
more...
|
|
Meeting Announcements |
2011 AACI/CCAF Annual Meeting
2011 AACI/CCAF Annual Meeting
October 16-18
Mandarin Oriental
Washington, DC
Please find the meeting registration, hotel information, preliminary program and speakers list on the AACI website:
http://www.aaci-cancer.org/annual_meeting/index.asp
|
